Suneet Varma is Global President, Rare Disease Business Unit, one of Pfizer’s fastest growing, high science units, which includes a broad gene therapy program. Our aspiration is to be the World’s Leading Innovator in Rare Disease, by pioneering breakthroughs that have a profound impact on the lives of underserved patient populations. Prior to this role, Suneet was Global President, Hospital Business Unit, one of Pfizer’s largest units which impacts the lives of over 200 million patients annually.
Suneet was recognized as one of the 2019 Outstanding 50 Asian Americans in Business by the Asian American Business Development Center. He currently sits on The Board of Trustees of Drew University.